These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8249174)

  • 1. Genetic events responsible for colorectal tumorigenesis: achievements and challenges.
    Kopnin B
    Tumori; 1993 Aug; 79(4):235-43. PubMed ID: 8249174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
    Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
    Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of colorectal cancer (part 1).
    Wilson RH; Whiteside MC; Russell SE
    Clin Oncol (R Coll Radiol); 1997; 9(1):14-9. PubMed ID: 9039808
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic alterations in the adenoma--carcinoma sequence.
    Cho KR; Vogelstein B
    Cancer; 1992 Sep; 70(6 Suppl):1727-31. PubMed ID: 1516027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma.
    Ko JM; Cheung MH; Kwan MW; Wong CM; Lau KW; Tang CM; Lung ML
    Int J Cancer; 1999 Aug; 84(4):404-9. PubMed ID: 10404094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
    Brewster SF; Browne S; Brown KW
    J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistep carcinogenesis in colorectal cancers.
    Takami K; Yana I; Kurahashi H; Nishisho I
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
    Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic changes in carcinoma of the colon].
    Lazo PA
    Med Clin (Barc); 1992 Sep; 99(9):350-4. PubMed ID: 1435007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of molecular mechanism in colorectal tumorigenesis].
    Shirasawa S
    Fukuoka Igaku Zasshi; 1993 Jan; 84(1):25-35. PubMed ID: 8458595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.
    Cho KR; Vogelstein B
    J Cell Biochem Suppl; 1992; 16G():137-41. PubMed ID: 1469893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.
    Ji X; Tang J; Halberg R; Busam D; Ferriera S; Peña MM; Venkataramu C; Yeatman TJ; Zhao S
    BMC Cancer; 2010 Aug; 10():426. PubMed ID: 20707908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
    Cawkwell L; Lewis FA; Quirke P
    Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
    Goyette MC; Cho K; Fasching CL; Levy DB; Kinzler KW; Paraskeva C; Vogelstein B; Stanbridge EJ
    Mol Cell Biol; 1992 Mar; 12(3):1387-95. PubMed ID: 1347643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
    Chiang JM; Chou YH; Chou TB
    Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.
    Baisse B; Bouzourene H; Saraga EP; Bosman FT; Benhattar J
    Int J Cancer; 2001 Aug; 93(3):346-52. PubMed ID: 11433398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.